Erick Gamelin - Chief Development Officer at Acrivon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
ACRV on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Erick Gamelin since 12/4/2023

Holdings reported by Erick Gamelin for Acrivon Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 17K $134K $7.92 Nov 14, 2024 Direct
Stock Option (Right to Buy) 45K Mar 1, 2024 Direct Common Stock

Transactions reported by Erick Gamelin for Acrivon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.